Von Willebrand factor D'-D3 domain interface (VWF D'-D3)

The Von Willebrand factor (VWF) D'-D3 domain interface is a specialized structural region located at the N-terminus of the VWF protein, specifically encompassing residues 764 to 1240 (UniProt: P04275). Its primary biological role is to serve as the high-affinity binding site for coagulation Factor VIII (FVIII), a partnership essential for protecting FVIII from premature proteolytic degradation by activated protein C and rapid clearance from the bloodstream (PubMed: 31697366). This interface is a critical determinant of FVIII pharmacokinetics; without VWF binding, FVIII has a half-life of only 1-2 hours, whereas the VWF-bound form lasts approximately 12-15 hours (NIH: StatPearls). Mutations within this specific interface lead to Von Willebrand Disease Type 2N, which clinically mimics Hemophilia A due to the inability of VWF to chaperone FVIII. In modern pharmacology, the D'-D3 interface is leveraged to develop long-acting FVIII replacement therapies, such as efanesoctocog alfa (BIVV001). By incorporating a D'-D3 domain fragment into the drug design, researchers can decouple FVIII from endogenous VWF, successfully bypassing the "VWF ceiling" and extending the therapeutic half-life to over 40 hours (NEJM: 388:310-318). This makes the D'-D3 interface a pivotal therapeutic target for reducing the frequency of infusions and improving prophylaxis in patients with bleeding disorders.

Other names

VWF D'D3 regionFactor VIII binding domain of Von Willebrand factorVWF amino-terminal D'D3 domainsVWF-FVIII binding interface

Stabilization and protection of Factor VIII from premature clearance by providing a high-affinity binding scaffold that mimics the natural VWF-FVIII interaction, thereby extending the circulatory half-life of Factor VIII.